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1. ABSTRACT 
 
Amitraz is an important product for the control of cattle ticks around the world. In comparison with other products for 
the control of ticks, it is quite affordable and it has a rapid knock-down effect. It binds with and activates adrenergic neuro-
receptors of animals and it inhibits the action of monoamine oxidases (MAO). Resistance to amitraz has been documented in 
Rhipicephalus microplus, R. decoloratus and R. appendiculatus. Four mechanisms of resistance have been proposed, each of 
which is supported by evidence but none of which has been definitively confirmed as the cause of resistance in the field. The 
proposed mechanisms include genetic target site insensitivity in two G protein-coupled receptors, the beta-adrenergic octopamine 
receptor (BAOR) and the octopamine/tyramine receptor (OCT/Tyr), increased expression or activity of monoamine oxidases and 
increased expression or activity of the ATP binding cassette transporter.  
 
2. INTRODUCTION 
 
Amitraz is a widely used, affordable and relatively safe short-acting acaricide for use by spray or plunge dip. It has 
been available for over 40 years and resistance has been reported with increasing frequency in recent years. Research into the 
mechanisms of acaricide resistance has generated several lines of enquiry but so far none of the proposed mechanisms has been 
confirmed using functional studies. This review is intended to provide an overview of current knowledge and understanding of 
the possible mechanisms of amitraz resistance in rhipicephaline ticks. 
 
3. AMITRAZ 
 
3.1. Structure and chemical characteristics 
 
Amitraz is listed and described on PubChem Open Chemistry Database as CID36324 or BTS-27419. Its molecular 
formula is C19H23N3 and its structure is as shown in Figure 1. It has many synonyms, including U-36059. Amitraz has been 
widely used as an acaricide since its discovery and reporting in 1972 by the Boots Company (1). Although pour-on products with 
amitraz have been developed for Sarcoptes mites affecting pigs, in cattle it is formulated for use as an aqueous dip or spray, at a 
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concentration of 0.2.5 g/l (2). Although soluble in most organic solvents, it is not soluble in water, which leads to some 
challenges with formulation. Amitraz is rapidly absorbed and is primarily excreted in the urine in the form of 5 degradation 
products, of which N′-(2,4-dimethylphenyl)-Nmethylformamidine (BTS-2721) and 2,4-dimethylformanilide (BTS-27919) 
predominate, both of which are regarded as potentially having genotoxic effects (3).  
 
3.2. Amitraz as an acaricide 
For application to cattle using aqueous sprays or dips, it is formulated as either an “emulsifiable concentrate” (EC), 
often used in spray races, or as a “wettable powder” (WP), often used in dipping vats. The WP formulation, in particular, is prone 
to sedimentation in the dipping vat and requires vigorous and regular agitation to ensure that the active compound is in 
suspension. To add to the challenges of its use, amitraz is not stable under acidic pH conditions (4) and it requires buffering with 
lime to maintain an alkaline pH, ideally of pH = 12 (5). Whereas the compound is relatively stable at neutral pH in sterile 
solutions, in the pH range 7 to 11, amitraz is co-metabolised by bacteria in fouled dipping solutions. These processes are blocked 
at alkaline pH >11.5.(5).  
 
The efficacy of amitraz as an acaricide for several species of tick including R. microplus and R. annulatus has been 
established (eg (6)). Treatment with 0.1.25 g/l and 0.2.5 g/l amitraz both provided > 97% control of ticks, accompanied by a 
reduction in the weights of and reduced egg production by any surviving female ticks. The application of amitraz to animals for 
the control of ticks is characterised by rapid detachment of all stages of the tick from the host, with subsequent mortality. Ticks 
begin to detach from the host within one hour of application and are completely or mostly cleared from the host within 7 hours 
(6, 7). Amitraz is considered to be a short-acting acaricide but it does have residual efficacy for 7 to 10 days (6, 7). 
Although it is not currently a recommended or legal strategy, Harrison and Palmer (2) describe the use of amitraz in 
pasture and on vegetation to control R. microplus and Haemaphysalis longicornis. Application of 0.5. g/l amitraz to pastures 
(equivalent to 667 g/ha) resulted in >90% mortality of free-living R. microplus larvae. Application of 200 to 800 g/ha of amitraz 
by aerial spraying resulted in a 50 to 80% reduction in nymphs of H. longicornis. 
 
In comparison with commercially available pour-on and injectable products, amitraz is cheap and where there are no 
resistance problems the correctly formulated and applied product provides a rapid knockdown effect. Amitraz is commonly used 
by small-holder cattle producers in Africa, where hand-sprays are often used, and macrocyclic lactones are unaffordable for 
smallholders. A recent study in Uganda (8) showed that 37% of all acaricides used for tick control were amitraz. In Zambia, 27% 
of treatments against ticks were with amitraz (9). 
 
3.3. Biological effects of amitraz  
The application of amitraz to ticks on cattle is followed by behavioural changes including detachment, then by 
mortality or reduced weight of ticks and reduced egg production (6, 7). Hence, amitraz causes a wide range of effects in 
mammals and arthropods and it appears that its effects are mediated by enzyme inhibition and by binding with neuroreceptors.  
 
The first proposed mechanism for acaricidal effects of the related compound chlordimeform was the inhibition of 
monoamine oxidase (MAO) (10). Amitraz (described in the paper as U-36059) was subsequently shown to be a more potent 
inhibitor of monoamine oxidases in rat liver than chlordimeform (11). The I50 concentration (the concentration providing 50% 
inhibition of MAO activity) of amitraz (U-36059) was 6.6. × 10-7, which suggests that it has 20-fold higher activity than 
chlordimeform, which had an I50 value of 1.4. × 10-5. Yim et al. (12) subsequently showed that the amidine acaricides 
chlordimeform and amitraz were potent anti-inflammatory compounds in rats and suppress prostaglandin synthesis by inhibition 
of prostaglandin synthetase activity. Compared with indomethacin and aspirin in a rat model of prostaglandin synthetase 
inhibition, the order of potency was indomethacin > chlordimeform > amitraz > aspirin.  
 
Amitraz is identified on PubChem (13) as an adrenergic alpha-2 receptor agonist, and there is a considerable body of 
evidence that G protein-coupled receptors are the main targets of the compound in mammals. Shin & Hsu (14) clearly showed 
that amitraz acts via alpha-adrenoceptors and that the effect can be blocked by yohimbine, an alpha-adrenoceptor-like antagonist. 
Amitraz also behaves as a histamine H1 receptor antagonist (15). In insects and acari, it has been proposed to bind with the 
octopamine receptor (16, 17) or the octopamine/tyramine receptor (18, 19).  
 
4. RESISTANCE TO AMITRAZ IN TICKS 
 
4.1. Bioassays for the diagnosis of amitraz resistance 
Diagnosis of amitraz resistance in R. microplus is based on in vitro bioassays, of which there are four main variants in 
common use at present. The adult immersion test (AIT) is the simplest of these assays and involves immersion of fully engorged 
female ticks in commercial acaricide for 30 minutes and subsequent incubation for 7 days (20). The Shaw larval immersion test 
(SLIT) uses 300-500 larvae of 14 – 21 days old, which are placed in a filter paper sandwich and washed with 10 ml of the test 
compound for 10 minutes, after which larvae are incubated in filter paper tubes for 17-18 h, when mortality is assessed (21). The 
larval packet test of Stone and Haydock (LPT) has been the most widely used test, in which filter paper envelopes are 
impregnated with technical grade acaricide in oil, filled with 100 larvae of 14 - 21 days old and incubated for either 24 or 48 h 
before assessment of mortality (22). The LPT has been modified to improve its performance with amitraz (23) and its 
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performance has been shown to be superior to the AIT, which should be regarded as an unsatisfactory bioassay for amitraz 
resistance (20). A recent innovation has been the development of the larval tarsal test (LTT) in which 50 eggs are placed in each 
of the required number of wells of a 96-well plate after pre-treating the wells with the acaricide in oil. The plate is sealed and 
incubated for two weeks prior to visual assessment of mortality (24). This bioassay enables the testing of a large number of 
replicates with no handling of larvae at all. The predictive value of a positive diagnosis using the LPT and the SLIT has been 
questioned in the past (25-27).  
 
4.2. Prevalence of resistance to amitraz 
Resistance to amitraz has been documented in several tick species. A recent study from Uganda (8) demonstrated 
resistance to amitraz in R. decoloratus and R. appendiculatus using the larval packet test and using a discriminating concentration 
of double the LC99 for susceptible populations. The prevalence of amitraz resistance in R. microplus has been documented in 
many studies conducted around the world (9, 28-32).  
 
4.3. Proposed mechanisms of resistance to amitraz 
Polymorphism and consequent target site insensitivity of two G protein-coupled receptors (GPCR) has been associated 
with amitraz resistance in R. microplus. Chen et al. (18) identified two amino acid substitutions that are present in the 
octopamine/tyramine receptor of amitraz-resistant isolates but not in susceptible isolates. These results were confirmed by Baron 
et al. (19). Corley et al. (33) identified an amino acid substitution in the resistant populations of R. microplus and showed that the 
proportion of this variant increased in populations subjected to selection with amitraz at a rate that was proportional to the 
increase in resistance as measured in the LPT bioassay for amitraz. A variant of R. microplus beta-adrenergic octopamine 
receptor (RmBAOR) was amplified from an amitraz-resistant tick strain (Colombia). The variant contained a 36 bp insertion in the 
first trans-membrane domain, resulting in a predicted extension to the extracellular N-terminal chain, was identified in cell 
culture from an amitraz-resistant isolate (34). The same study also found what appeared to be a duplicate RmBAOR gene only in 
one of the amitraz-resistant isolates, but its sequence identity is unknown. Expression of the ATP binding cassette B10 transcript 
(ABCB10) was also elevated in the same cell-line, which originated from ticks that were cross-resistant to organophosphate and 
organochlorine acaricides. This is consistent with the work of Lara et al. (35), who showed that amitraz-resistant R. microplus 
ticks detoxified amitraz more efficiently than amitraz-susceptible ticks and this was associated with increased levels of ABCB10 
expression. There are no published reports of the relationship between polymorphism and/or transcript expression levels of 
monoamine oxidase and resistance to amitraz. However, there are preliminary data from two studies on the subject. The first 
comes from an MSc project conducted by Xiarong Jiang in 2006 (36). The second work is a small, exploratory study by Jonsson 
& Corley, conducted in 2009. The results of these studies are inconclusive. 
 
5. TARGET-SITE INSENSITIVITY - G PROTEIN-COUPLED RECEPTORS AND THEIR POTENTIAL ROLE IN 
AMITRAZ RESISTANCE 
 
5.1. G protein-coupled receptors – structure and function 
Some knowledge of GPCR structure and function is essential for the understanding of the potential roles in amitraz 
resistance of the BAOR, of OCT/Tyr receptor and of MAO. The GPCRs are diverse proteins that mediate second-messenger 
signalling at the cell membrane and constitute the largest protein superfamily of mammalian genomes (37). Ligands or triggers 
for GPCRs are diverse and range from photons through ions, amines, nucleotides, peptides, lipids and proteins (38). All members 
of the GPCR superfamily have seven hydrophobic, membrane-spanning alpha-helices, each of about 25-35 residues, which form 
a receptor or recognition and connection unit, which is coupled with and can interact with a G protein (38). Beyond these 
essential characteristics, there is considerable diversity in structure and function, particularly in relation to the alternative 
signalling pathways that are triggered by activation of the associated G proteins. On the basis of DNA sequence analysis of the 
genes coding the receptors, which are not well conserved among homologs (or paralogs) in different taxa, there are five main 
families of GPCR: secreting receptor family, adhesion receptor family, glutamate receptor family, frizzled/taste2 receptor family, 
and the rhodopsin family (38). In this classification scheme, octopamine, serotonin, tyramine, dopamine and 
octopamine/tyramine receptors all belong to the amine receptor cluster within the alpha-group of rhodopsin receptors within the 
rhodopsin family (38). Although the 7 transmembrane domain structure is consistent, there is much diversity in the N-terminal 
chain and in the extracellular loops, resulting in substantial variation in the size, shape and electrostatic properties of the ligand 
binding pockets, particularly among GPCR subfamilies (37).  
 
The structure and function of GPCRs have been described in detail (37). In brief, inactive and active GPCR in the cell 
membrane are bound with heterotrimeric G protein (Galpha, Gbeta and Ggamma subunits). Binding of a ligand results in varying 
degrees of conformational change to one or more of the 7 transmembrane alpha-helices, which enables interaction of the the 
Galpha subunit with a domain of the GPCR that functions as a guanine nucleotide exchange factor (GEF). This interaction results 
in the exchange of GDP that is bound to the Galpha subunit for GTP. This process is the activation of the G protein, which results 
in dissociation of Galpha from Gbetagamma. The activated Galpha subunit then goes on to activate one of several possible signalling 
pathways. The dominant two pathways are via adenylyl cyclase (AC), generating cAMP, and via phospholipase C-beta, 
generating inositol (1,4,5) triphosphate (IP3) and diacylglycerol (DAG). The IP3 binds with receptors on the membrane of the 
endoplasmic reticulum to cause intracellular release of Ca2+ and the DAG binds with a member of the protein kinase C (PKC) 
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family. These pathways and the relative dispositions of octopamine and tyramine signalling are nicely illustrated by Farooqui 
(39).  
 
5.2. Classification of G protein-coupled receptors in ticks 
Invertebrate GPCR share very low levels of identity with mammalian GPCR, although their ligands are more similar. 
Insect octopamine receptor classification has been recently revised, as shown in Table 1 (39,40). This classification seems 
broadly compatible with the limited information available for ticks, although the convention for naming receptors has not been 
applied consistently. Corley et al. (41) generated full length cDNA sequences for 8 putative GPCR from R. microplus, including 
one OCTbeta2-R and one OCTalpha-R, which were referred to as Rm_beta2AOR (Rhipicephalus microplus beta-2 adrenergic-
like octopamine receptor) and Rm_alpha2AOR (Rhipicephalus microplus alpha-2 adrenergic-like octopamine receptor). In 
subsequent work examining SNPs in the Rm_beta2AOR associated with amitraz resistance, it was referred to as RmBAOR (33). 
The gene that Baxter & Barker (17) and subsequent workers examined (18, 19, 42, 43) was initially described as an octopamine-
like GPCR. Subsequently, Chen et al. (18) referred to it simply as a putative octopamine receptor. The phylogenetic analysis of 
Corley et al. (41) classed it as a tyramine/octopamine receptor. Baron et al. (19) referred to it as OCT/Tyr receptor and Gross et 
al. (42) followed the approach of Verlinden et al. (44) and Farooqui (39) by referring to it as a tyramine receptor (TAR1). By 
definition, classification implies comparison among genes, and the rapid and somewhat confusing evolution of nomenclature is a 
result of ambiguities/errors in annotations that persist in public databases. Given their importance in acaricide development and 
drug resistance, an attempt should be made by the acarine community to standardise the nomenclature of acarine GPCRs. One 
important consideration in relation to the proposed mechanisms of resistance discussed below is ligand-receptor specificity, 
which is not often a binary characteristic. Tyramine is the final biosynthetic intermediate in octopamine production and as 
discussed by Lange (45), this has led to the view that its importance as a neurotransmitter in its own right is somewhat less than 
that of octopamine, being largely considered to be a partial agonist for octopamine at octopamine receptors. However, there is a 
spectrum of activity shown by octopamine and tyramine, with sometimes differential effects on the same receptor, as shown in 
Table 1. There are few recent pharmacological studies of acarine GPCRs, however Gross et al. (42) clearly demonstrated that 
although the effect of tyramine at the TAR1 receptor is 39 times more potent than the effect of octopamine, both are agonists. 
 
5.3. Octopamine and tyramine and their receptors in ticks – evidence for their role in amitraz resistance 
Octopamine has a very wide range of physiological and behavioural functions, which are discussed extensively 
elsewhere (39). In arthropods, as a neurotransmitter, it modulates neuromuscular transmission, muscle metabolism and sensory 
signals and influences the functional responses of innervated organs. In the haemolymph, it functions as a neurohormone, 
modulating haemocyte recruitment and phagocytic ability in the face of microbial challenge, and lipid mobilisation during 
extended motor activity. Amitraz affects all of these known physiological functions of octopamine; thus it is hypothesized that 
resistance to amitraz is mediated by a) alterations to amitraz degradation leading to its inactivation before interacting with 
octopamine or tyramine neuroreceptors (metabolic resistance), b) alterations to these neuroreceptors resulting in reduced amitraz 
binding (target site insensitivity), and c) modified reuptake of amitraz from the synaptic space. Currently there is evidence in 
support of a) and b) above. Among GPCRs of the biogenic amine group, transmission is largely modulated by the activity at the 
neuronal cell membrane of transporter proteins, which resorb (“re-uptake”) free neurotransmitters from the synaptic cleft. 
Examinations of this process in acarine systems have not been published to date. 
 
5.3.1. Octopamine/tyramine receptor 
The potential role of this receptor was first examined by Baxter and Barker, who found that there was no association 
between cDNA sequence of the gene and resistance to amitraz in two strains of ticks in Australia (17). The susceptible N-strain 
had exactly the same sequence as the amitraz-resistant Ultimo strain and it was concluded that resistance to amitraz was not 
mediated by polymorphisms in this gene. Subsequent work conducted using North American populations of susceptible and 
resistant R. microplus identified two SNPs that were only present in amitraz-resistant isolates (18). The strains were Gonzalez 
(susceptible), Santa Luiza (selected with amitraz and resistant, originally from Brazil), San Alfonso (highly resistant to amitraz, 
from Mexico), Pesqueria (low level of resistance to amitraz – RR = 4 relative to Gonzalez, also from Mexico), Coatzacoalcos 
(amitraz susceptible but synthetic pyrethroid resistant), Tuxpan (organophosphate resistant but amitraz susceptible) and Corrales 
(amitraz susceptible but synthetic pyrethroid resistant). The complete open reading frame cDNA sequences from each were 
compared with that of the Australian sequences (17) and there were 37 nucleotide substitutions (~ 97% identity) and 7 amino acid 
substitutions (~98% identity). The San Alfonso and Santa Luiza strains shared two non-synonymous SNPs (A22C – T8P; T65C – 
L22S) that were absent from the other tick strains, including the Australian strains. Both SNPs were in the N-terminal, first 
extracellular domain, suggesting a possible role for conformational change in the octopamine/tyramine receptor in resistance to 
amitraz. 
 
Baron et al. (19) examined South African field samples of R. microplus and demonstrated that the SNPs causing amino 
acid substitutions T8P and L22S, as previously identified in North America (18), were present in the resistant samples. They also 
showed a very tight relationship between survival of larvae in the LPT and the genotype. Every one of seven larvae that survived 
was homozygous for the putative resistance-conferring allele at both loci and none of the six larvae that did not survive the LPT 
were homozygous for the putative resistance-conferring alleles at the two loci. This clearly strengthens the evidence that 
polymorphism in the octopamine/tyramine gene contributes to the amitraz-resistance phenotype. These workers showed that the 
two SNPs were in linkage disequilibrium and suggested that balancing selection arising from a fitness cost of the resistant alleles 
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might contribute to the observed allelic frequencies. They also developed an RFLP-based assay for amitraz resistance and used it 
successfully in a field survey (43). 
 
5.3.2. Beta-2-adrenergic-like octopamine receptor 
Several mutations have been detected in this gene that have been associated with resistance to amitraz. Corley et al. 
(33) identified a non-synonymous mutation in the beta-2-adrenergic-like octopamine receptor in the same amitraz-resistant 
Ultimo strain of ticks as used by Baxter and Barker (17, 18), which resulted in a I61F amino acid substitution. In a three-year 
field trial in which varying degrees of selection with amitraz was applied to cattle with accompanying genetically isolated tick 
populations on replicate small farms (farmlets), the frequency of the homozygote putative resistance-conferring homozygous 
(FF) genotype closely matched the observed proportion of resistance to amitraz by the LPT. In the tick populations on the two 
farmlets to which amitraz selection was applied most intensively, the frequency of the putative resistance allele increased from 10 
and 21% to 97 and 93% respectively over two years. On the two farmlets in which amitraz was not used there were reductions in 
the frequency of the putative resistance-conferring alleles. The correlation between percentage resistance in the LPT and 
frequency of the FF genotype was 0.9.0 and between the percentage resistance and the homozygous II genotype was -96%. An 
additional SNP in the RmBAOR was reported in a field sample at the next amino acid residue (I62T), however the resistance 
status of this population was not known. 
 
Work with cell lines from R. microplus, five other Rhipicephalinae and three other genera (Amblyomma variegatum, 
Ixodes ricinus, Hyalomma anatolicum) recently resulted in the discovery of further polymorphism associated with amitraz 
resistance in the RmBAOR (34). Two of the cell lines (BME/CTVM6 and BME/CTVM5) were initiated in 1983 from a single 
isolate of ticks (Paso Ancho from Colombia), considered to be resistant to amitraz. Both of these cell lines yielded gDNA and 
cDNA amplicons that were larger (~245 and ~220 bp) than the 183 bp generated from each of the amitraz-susceptible 
populations. The 220 bp products from the BME/CTVM5 and BME/CTVM6 cell lines were sequenced and both revealed a 36 bp 
duplication insertion at position 190, which was predicted to result in an extended N-terminal extracellular domain (Figure 4). 
The approximate 245 bp product was not sequenced due to multiple primer binding sites, leading to the interpretation that there is 
an additional, related gene.  
 
In subsequent work that is being prepared for publication, we have analysed gDNA sequences of RmBAOR from 
samples of ticks from diverse locations around the world, including Brazil, Mexico, Australia, Thailand, and South Africa. We 
used the primers described previously (forward: GAAATCTGACGGACGAGGAA; reverse: GCGACACGATGAAGTAGTTG; 
(34)) and have identified several SNPs listed in Table 2 and shown graphically in Figures 3 and Figure 4, which are specific to 
populations in which amitraz resistance was confirmed. This work has confirmed the presence of the I61F mutation in amitraz-
resistant South American isolates of R. microplus and strengthens the belief that variation in RmBAOR might contribute to 
resistance to amitraz. 
 
6. DETOXIFICATION MECHANISMS 
It is likely that detoxification plays a role in resistance to amitraz in a similar manner to the roles that detoxification 
mechanisms contribute to the well-documented resistance to synthetic pyrethroids (SP). In the SP model, three mutations have 
been identified in the para-sodium channel gene (46-48), yet there is a mixed picture in the field, with some cases of resistance to 
SPs (generally with lower resistance ratios) being attributable to elevated esterase activity (49).  
 
6.1. Monoamine oxidases 
Variation in the structure or level of expression of monoamine oxidases has been considered as a possible mechanism 
of resistance in R. microplus, although little or no information is available in the public domain. There are several pathways of 
enzymatic degradation of octopamine in insects, including beta-alanine, glutamate and sulfate conjugation (39). Whereas MAO is 
believed to be of little importance in insects (50), its activity has been demonstrated in R. microplus by Holden & Hadfield (51), 
who showed that although MAO was inhibited by chlordimeform, this was not the main mechanism of toxicity. Further, 
identification of the correct gene encoding MAO has proven to be a challenge. The early work by Jiang (36), targeting a putative 
monoamine oxidase, appears to have amplified a putative lysine-specific histone demethylase, based on sequence comparison 
with the publicly available Ixodes scapularis genome. More recently, we undertook a small, exploratory sequencing and gene 
expression study, comparing 6 ticks of the amitraz-resistant Ultimo strain with 6 ticks of the amitraz-susceptible Mount Alford 
strain from Australia. We targeted a putative monoamine oxidase using primers derived from R. microplus ESTs (Table 3, by Dr 
Paula Moolhuijzen of the Centre for Comparative Genomics, Murdoch University) and found that there was no variation in 
sequence among the samples. Gene expression using high resolution melt qRT PCR showed no significant difference in the level 
of expression of the two strains, however as seen in Figure 5, from our data, the observed trend to higher expression in resistant 
ticks suggests that there might be some value in investigating this further. 
 
6.2. ATP binding cassette transporter activity 
 ATP-binding cassette (ABC) transporters are an important family of integral membrane glycoproteins that are 
implicated in the elimination of xenobiotic lipophilic substances from cells after prior chemical modification and conjugation to 
an anionic moiety (52). ABC transporters mostly function to pump xenobiotic compounds out of the cytoplasm and into the 
extracellular space (or more generally across the membranes of other organelles), and they have been associated with 
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anthelmintic resistance in parasitic nematodes (53). A recent study by Lara et al. (35) reported on the expression and activity of 
RmABCB10, a PgP-1-type ABC transporter, and the metabolism of amitraz in amitraz-resistant and amitraz-susceptible strains of 
R. microplus. They found that the ABCB10 glycoprotein is responsible for the transport of heme from the digestive vesicle to the 
hemosome and that amitraz was similarly dependent on ABCB10 for its incorporation into the hemosome. The expression of 
RmABCB10 and the cyclosporine A-sensitive uptake of a labelled protoporphyrin marker were both elevated in ticks that were 
resistant to amitraz (Ibirapua strain) compared with those that were susceptible (Porto Alegre or POA strain). These results are 
consistent with studies using cell cultures from R. microplus (34). RmABCB10 expression was significantly higher in a cell line 
(BME/CTVM6) that was derived from R. microplus ticks that were resistant to amitraz, organophosphates and organocholorine 
compounds, relative to five other cell lines. However, in another cell line (BME/CTVM5) derived from the same original 
Colombian isolate (Paso Ancho), the expression of RmABCB10 did not differ from that of the other cell lines. Taken together, 
these two studies (34, 35) suggest that the effects of amitraz on ticks are likely to be at least partially mediated by ABCB10 
activity. 
 
7. SUMMARY AND PERSPECTIVES 
 
 Although at present there is no unambiguous proof of the role of any one specific mechanism in conferring resistance 
to amitraz in R. microplus, there are consistent and strong associations between mutations of GPCRs and resistance to amitraz in 
R. microplus. Amitraz-resistant isolates from Australia and Latin America share mutations in the N-terminal extracellular domain 
and in the first few amino acid residues of the first transmembrane domain of RmBAOR. Similarly, amitraz-resistant isolates from 
the USA, Latin America and South Africa share mutations in the octopamine/tyramine receptor. It is possible that mutation of 
either of these GPCR could independently interfere with the action of amitraz on ticks or that the two genes are in tight linkage 
disequilibrium, such that one is a predictor for the other. Unfortunately, no studies have been reported yet in which both of these 
GPCR have been genotyped in the same individual, leaving these possibilities unresolved. Clear definition of the roles of the 
genes would be dependent on in vitro studies using a standardised reporter system, in which the pharmacological properties of 
putative susceptible and resistant receptors can be compared. Given that several mutations have been detected to date and more 
are possible, the development of a single, comprehensive diagnostic test based on DNA sequence variation alone is likely to be 
difficult. It is possible that resistance to amitraz is mediated by ABC transporter proteins and by monoamine oxidases, among 
other enzymes; however these mechanisms, if present, would result in lower resistance ratios than those expected from target site 
insensitivity.  
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Table 1. Classification scheme of octopamine receptors according to intracellular signalling, ligand affinity and DNA sequence 
OCTα-R 
(α-adrenergic-like) 
OCTβ-R 
(β-adrenergic-like) 
TYR1-R TYR2-R 
↑ Ca2+ 
{↑} cAMP 
OCT > TYR 
↑ cAMP 
OCT > TYR 
↓ cAMP (TYR > OCT) 
↑ Ca2+ (OCT > TYR) 
 
↑ Ca2+  
TYR 
 
 These split into 
OCTβ1-R 
OCTβ2-R 
OCTβ3-R 
  
 
 
 
Table 2. SNPs identified in RmβAOR sequences 
Position  SNP Amino Acid 
123 T → C Synonymous  
126 C → T Synonymous 
181 A → T I → F 
185 T → C I → T 
225 A → G Synonymous 
263 A → C Y → S 
264 C → A Y → S 
 
 
 
Table 3. Sequencing and RT-PCR primers for putative monoamine oxidase 
Name Primer sequence Location and Product 
MAOB-F1 GACGGACAGTACCCGGCCA  Pos 19 (619 bp product with MAOB-R1) 
MAOB-F2 TATCGTCGATAACGTCCCTAGA Pos 565 (707 bp product with MAOB-R2) 
MAOB-R1 CTACCAAGGCTACCATGCATG Pos 638 (619 bp product with MAOB-F1) 
MAOB-R2 TAATAATTCGGTGAGGCACACAA Pos 1272 (707 bp product with MAOB-F2) 
MOAB RT-F CATTGGGCGGCTTCACTTC 67 bp product with MAOB RT-R 
MOAB RT-R GCTTGGATGGCACCGTTGA  
 
 
 
Figure 1. Two-dimensional (L) and three-dimensional (R) structure of the amitraz molecule (Source: PubChem URL: 
https://pubchem.ncbi.nlm.nih.gov). Data deposited in or computed by PubChem. 
 
10 
 
 
 
Figure 2. Location of putative amitraz resistance-conferring amino acid substitutions T8P and L22S in the octopamine/tyramine 
receptor, as described previously (18, 19). 
 
Figure 3. Location of putative amitraz resistance-conferring amino acid substitutions in the RmβAOR. 
 
Figure 4. Location of the 12 amino acid insertion and SNP in the BME/CTVM6 cell line of the putative beta-adrenergic-like 
octopamine receptor of R. microplus 
 
Figure 5. Relative gene expression of monoamine oxidase in 6 adult female R. microplus ticks from the Mt Alford strain (MTA), 
known to be susceptible to amitraz and in 6 adult female ticks from the Ultimo strain, a population that is selected with amitraz 
and known to include individuals that are resistant to amitraz, but also to show some heterogeneity of response in bioassays. 
 
Running title: Molecular biology of amitraz resistance 
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